highperformr logo

Acellera Therapeutics's Overview

Total employees14
HeadquartersBarcelona
Founded2006

Acellera is a pioneering technology company specializing in developing and applying advanced computational methods to accelerate research in drug discovery, biomolecular research, and materials science. They are renowned for their high-performance molecular dynamics (MD) software, such as ACEMD, which leverages GPU technology to achieve unprecedented simulation speeds. Acellera also offers user-friendly platforms like PlayMolecule for broader access to complex simulation tools and HTMD (High-Throughput Molecular Dynamics) for managing and analyzing large MD datasets. Their solutions empower researchers in pharmaceutical companies, biotech firms, and academic institutions worldwide to gain deeper insights into molecular mechanisms and design better drugs and materials.

Where is Acellera Therapeutics's Headquarters?

HQ Function

The Barcelona headquarters serves as the central hub for Acellera's research and development, software engineering, business operations, and strategic partnerships. It's where core product development and scientific innovation take place.

Notable Features:

Situated within the Barcelona Science Park (Parc Científic Barcelona), providing access to a collaborative ecosystem of research groups, biotech companies, and advanced scientific facilities.

Work Culture:

Acellera fosters a dynamic, innovative, and scientifically-driven work culture. Employees, often with strong backgrounds in physics, chemistry, computer science, and biology, collaborate in a research-intensive environment focused on solving complex scientific challenges using cutting-edge computational tools.

HQ Significance:

The Barcelona location is strategically important due to its proximity to leading universities, research centers, and a thriving biotech industry, facilitating talent acquisition and scientific collaborations across Europe.

Values Reflected in HQ: The headquarters' location and setup reflect Acellera's commitment to innovation, scientific excellence, collaboration, and cutting-edge technology.

Location:

Acellera supports a global clientele of pharmaceutical companies, biotech firms, and academic research institutions across North America, Europe, and Asia. Their functions supported globally include software licensing and distribution of their flagship products (ACEMD, PlayMolecule, HTMD), dedicated technical support, scientific consulting services for complex molecular modeling and drug discovery projects, and fostering international research collaborations. While physical offices are concentrated in Spain, the UK, and the US, their reach and support extend worldwide through digital platforms and partnerships.

Street Address:

Barcelona Science Park, Carrer de Baldiri Reixac, 10, Office 2.20

City:

Barcelona

State/Province:

Catalonia

Country:

Spain

Acellera Therapeutics's Global Presence

London, UK

Address: London BioScience Innovation Centre, 2 Royal College St, London NW1 0NH, United Kingdom

To serve clients and partners in the United Kingdom and potentially Northern Europe, leveraging London's status as a global hub for biotech and finance.

Cambridge, MA, USA

Address: Cambridge, MA, USA (Specific street address not publicly listed for general office; likely a representative or shared office space for US operations)

To facilitate engagement with US-based pharmaceutical companies, research institutions, and academic collaborators, providing local support for Acellera's software and services.

Buying Intent Signals for Acellera Therapeutics

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Executive Team of Acellera Therapeutics

As of April 2025, Acellera Therapeutics' leadership includes:

Manuel Corpas - Chief Executive Officer (CEO)
Gianni De Fabritiis - Founder & Chief Scientific Officer (CSO)
Jordi Juarez - Chief Technology Officer (CTO)
Federico Comitani - Head of Drug Discovery

Investors of Acellera Therapeutics

Acellera Therapeutics has been backed by several prominent investors over the years, including:

EIC Fund (European Innovation Council)
Caixa Capital Risc (early-stage)
Various EU research grants and national funding programs (e.g., Horizon Europe, Spanish Ministry of Science)

Executive New Hires/Exits in the Last 12 Months

Hire0
Exits0

No major high-profile executive hires or departures at the C-suite level have been publicly announced by Acellera in the last 12 months. The company maintains a stable leadership team focused on its core scientific and technological advancements.

Technology (Tech Stack) used by Acellera Therapeutics

Discover the tools Acellera Therapeutics uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

Acellera Therapeutics Email Formats and Examples

Acellera commonly uses the email format combining the first initial of an employee's name followed by their last name. This is a standard professional format.

[first_initial][last]@acellera.com

Format

jdoe@acellera.com

Example

90%

Success rate

News and media

Acellera NewsMay 15, 2024

Acellera news title

Acellera and Intel to Present at ISC High Performance 2024: Innovations in GPU-Accelerated Molecular Dynamics. The presentation will focus on recent advancements in ACEMD3, leveraging Intel’s GPU technology for enhanced simulation performance....more

Acellera NewsMarch 7, 2024

Acellera news title

Acellera Achieves ISO 27001 Certification for Information Security Management, demonstrating its commitment to the highest standards of data security for its clients and partners in the drug discovery and biotech sectors....more

EIC Community (European Innovation Council)October 19, 2023

Acellera news title

EIC Interview with Gianni De Fabritiis, Founder of Acellera, discussing the company's journey, innovations in GPU-accelerated drug discovery, and the impact of EIC funding on their growth and research capabilities....more

Highperformr’s free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including Acellera Therapeutics, are just a search away.